10:02 IST
BSE
Patent
Godavari Biorefineries Patent
China's patent office granted Godavari Biorefineries a patent for compounds treating viral infections. The invention covers V-ATPase inhibition for medicament use.
Godavari Biorefineries Ltd
Godavari Biorefineries Ltd news stories on ALFA NewsRead the news →- Share price
- ₹225.96
- Market cap
- ₹1,156 Cr
- Revenue (annual)
- ₹1,988 Cr
- Net profit (annual)
- ₹3.53 Cr
- P/E (TTM)
- 5134.3×Sector 37.2×
- Promoter holding
- 63.31%+0.00% QoQ
- FII holding
- 0.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Financial Results 4Earnings Call 4Patent 3Legal & Regulatory 3Business Update 3Annual General Meeting 3Results Update 2Other Announcement 2Board Meeting Date 2Production Started 1Management Change 1Debt & Borrowing 1Capacity Expansion 1Annual Report 1
Time
3 announcements with these filters
10:03 IST
BSE
Patent
Godavari Biorefineries Patent
Godavari Biorefineries Ltd announced that the Japanese Patent Office granted its patent “5‑HYDROXY‑1,4‑NAPHTHALENEDIONE for use in cancer treatment.” The grant enhances the company’s IP portfolio for oncology therapeutics.
15:07 IST
BSE
Patent
Godavari Biorefineries Patent
Godavari Biorefineries was granted an Indian patent for a safe, cost-effective branched alcohol production process. This grant strengthens its bio-based chemicals intellectual property portfolio.
- Execution
- 20 years